Healthequity Earnings Estimate

HQY
 Stock
  

USD 66.75  0.06  0.09%   

Many public companies, such as Healthequity, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Healthequity's earnings estimates, investors can diagnose different trends across Healthequity's analyst sentiment over time as well as compare current estimates against different timeframes.
Healthequity is projected to generate 0.82 in earnings per share on the 31st of December 2022. Healthequity earnings estimates module stress-tests analyst consensus about projected Healthequity EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please check Risk vs Return Analysis.
  
Refresh
Gross Profit is likely to rise to about 457.2 M in 2022, whereas Profit Margin is likely to drop (0.06)  in 2022.

Healthequity Earnings Estimation Breakdown

Calculation of earning per share of Healthequity is based on official Zacks consensus of 5 analysts regarding Healthequity future annual earnings. Given the historical accuracy of 72.28%, the future earnings per share of Healthequity is estimated to be 0.82 with the lowest and highest values of 0.77 and 0.9, respectively. Please note that this consensus of annual earnings estimates for Healthequity is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -0.08
0.77
Lowest
Expected EPS 0.82
0.90
Highest

Healthequity Earnings Projection Consensus

Suppose the current estimates of Healthequity's value are higher than the current market price of the Healthequity stock. In this case, investors may conclude that Healthequity is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Healthequity's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2022

5

72.28%

-0.08

0.82

Healthequity Earnings History

Earnings estimate consensus by Healthequity analysts from Wall Street is used by the market to judge Healthequity's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Healthequity's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Healthequity Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

31.9 Million

Share
Accumulated Retained Earnings Deficit is likely to drop to about 141.5 M in 2022. Earning Before Interest and Taxes EBIT is likely to drop to about (31 M) in 2022 Issuance Purchase of Equity Shares is likely to rise to about 503.2 M in 2022, whereas Weighted Average Shares is likely to drop slightly above 72.9 M in 2022.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Healthequity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Healthequity in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
64.4066.6868.96
Details
Intrinsic
Valuation
LowReal ValueHigh
60.0870.6372.91
Details
Naive
Forecast
LowNext ValueHigh
61.9864.2666.54
Details
11 Analysts
Consensus
LowTarget PriceHigh
52.0064.8086.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Healthequity. Your research has to be compared to or analyzed against Healthequity's peers to derive any actionable benefits. When done correctly, Healthequity's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Healthequity.
Note that many institutional investors and large investment bankers can move markets due to the volume of Healthequity assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Healthequity. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Healthequity stock price in the short term.

Healthequity Earnings per Share Projection vs Actual

Actual Earning per Share of Healthequity refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Healthequity predict the company's earnings will be in the future. The higher the earnings per share of Healthequity, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Healthequity Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Healthequity, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Healthequity should always be considered in relation to other companies to make a more educated investment decision.

Healthequity Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Healthequity's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-06-06
2022-04-300.260.270.01
2022-03-22
2022-01-310.220.2-0.02
2021-12-06
2021-10-310.34660.350.0034
2021-09-08
2021-07-310.35990.40.040111 
2021-06-07
2021-04-300.31880.380.061219 
2021-03-15
2021-01-310.39930.420.0207
2020-12-07
2020-10-310.35840.410.051614 
2020-09-08
2020-07-310.27540.420.144652 
2020-06-02
2020-04-300.4360.43-0.006
2020-03-16
2020-01-310.36420.390.0258
2019-12-03
2019-10-310.22630.470.2437107 
2019-09-03
2019-07-310.35170.450.098327 
2019-06-04
2019-04-300.33960.410.070420 
2019-03-18
2019-01-310.22130.270.048722 
2018-12-04
2018-10-310.2540.280.02610 
2018-09-04
2018-07-310.27940.340.060621 
2018-06-04
2018-04-300.28020.310.029810 
2018-03-19
2018-01-310.08740.110.022625 
2017-12-05
2017-10-310.15890.170.0111
2017-09-05
2017-07-310.18130.210.028715 
2017-06-06
2017-04-300.1870.190.003
2017-03-21
2017-01-310.06950.08920.019728 
2016-12-06
2016-10-310.11560.12360.008
2016-09-06
2016-07-310.13290.160.027120 
2016-06-07
2016-04-300.12750.150.022517 
2016-03-22
2016-01-310.04290.070.027163 
2015-12-07
2015-10-310.070.080.0114 
2015-09-08
2015-07-310.080.090.0112 
2015-06-08
2015-04-300.090.10.0111 
2015-03-24
2015-01-310.030.040.0133 
2014-12-09
2014-10-310.040.050.0125 
2014-09-09
2014-07-310.040.060.0250 

About Healthequity Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Healthequity earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Healthequity estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Healthequity fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit176.1 M141.5 M
Earning Before Interest and Taxes EBIT-30.2 M-31 M
Earnings per Basic Share(0.53) (0.54) 
Earnings per Diluted Share(0.53) (0.54) 
Price to Earnings Ratio(100.83) (103.48) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA107 M95.1 M
Earnings before Tax-66.7 M-68.5 M
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices and health savings accounts. It also provides mutual fund investment platform and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts health reimbursement arrangements and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force benefits brokers and advisors and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.6 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.